Cutler Group’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-470
Closed -$1.92K 3819
2022
Q4
$1K Sell
470
-1,052
-69% -$4.5K ﹤0.01% 3922
2022
Q3
$6K Sell
1,522
-281
-16% -$1.44K ﹤0.01% 3463
2022
Q2
$8K Buy
1,803
+481
+36% +$3.47K ﹤0.01% 3343
2022
Q1
$11K Buy
1,322
+922
+231% +$6.48K ﹤0.01% 3524
2021
Q4
$3K Buy
400
+399
+39,900% +$3.79K ﹤0.01% 4464
2021
Q3
$0 Buy
+1
New +$9 ﹤0.01% 5711
2021
Q2
Sell
-7,500
Closed -$74K 5697
2021
Q1
$77K Buy
+7,500
New +$104K ﹤0.01% 1982

Other funds holding SRTA

Cutler Group's SRTA Position: Q1 2023 in Review

Cutler Group sold out of Strata Critical Medical Inc (SRTA) in Q1 2023, closing a stake of 470 shares — an estimated $1.92K sold.

Cutler Group first reported a position in SRTA in Q1 2021 and held it in 7 quarters. The position peaked at $77K in Q1 2021. 93 funds tracked by Wall St. Rank hold SRTA as of Q1 2023.

  • Cutler Group reported no remaining Strata Critical Medical Inc position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 470 Strata Critical Medical Inc shares in Q1 2023, an estimated $1.92K.
  • Cutler Group first reported a position in Strata Critical Medical Inc in Q1 2021 and held it in 7 quarters.
  • Cutler Group's Strata Critical Medical Inc position peaked at $77K in Q1 2021.
  • 93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.